Biochemical strategies to anticoagulation: a comparative overview

Area of Science:

• Biochemistry
• Pathophysiology
• Pharmacology

Background:

• Hypercoagulability is a significant risk factor for severe conditions like disseminated intravascular coagulation (DIC), thrombosis, and organ failure.
• Managing coagulation dysfunction presents a challenge for both researchers and clinicians.
• Understanding the pathophysiology of hypercoagulable states is crucial for developing effective treatments.

Purpose of the Study:

• To provide an overview of various anticoagulants.
• To discuss anticoagulants based on their inhibitory target sites within the extrinsic coagulation pathway.
• To highlight the potential of novel anticoagulation strategies and their impact on anti-inflammation.

Main Methods:

• Review of existing literature on natural and pharmacological anticoagulants.
• Categorization of anticoagulants based on their mechanism of action and target sites.
• Discussion of emerging molecular genetic approaches for anticoagulation.

Main Results:

• Anticoagulants are broadly classified into natural (e.g., Antithrombin, Activated Protein C, Tissue Factor Pathway Inhibitor) and pharmacological types.
• Pharmacological anticoagulants include warfarin, FXa inhibitors, and direct thrombin inhibitors.
• Novel strategies targeting upstream components of the extrinsic pathway and molecular genetic approaches show promise.

Conclusions:

• Effective anticoagulation is vital for managing hypercoagulable states and preventing life-threatening complications.
• Targeting the extrinsic pathway offers diverse therapeutic strategies.
• Anticoagulation has broader implications for anti-inflammatory effects, potentially improving overall human health.